High Tech Pharm Co., Ltd. (KOSDAQ:106190)

High Tech Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	11,781	7,759	3,483	7,880	11,275	1,038
Trading Asset Securities	1,075	-	1,882	-	1,363	-
Cash & Short-Term Investments	12,855	7,759	5,365	7,880	12,637	1,038
Cash Growth	62.59%	44.63%	-31.92%	-37.64%	1117.51%	-89.95%
Accounts Receivable	16,105	20,330	24,443	28,476	9,413	19,564
Other Receivables	32.35	27.43	40.1	78.47	58.39	112.9
Receivables	16,137	20,357	24,483	28,555	9,472	19,677
Inventory	34,931	34,813	25,498	14,676	17,708	18,632
Prepaid Expenses	1,347	1,304	1,191	885.83	545.12	1,078
Other Current Assets	840.12	1.13	33.78	43.53	126.73	51.48
Total Current Assets	66,111	64,234	56,571	52,040	40,488	40,477
Property, Plant & Equipment	69,898	72,002	75,001	74,934	80,544	85,205
Long-Term Investments	2,680	3,061	2,076	2,198	1,768	2,468
Long-Term Deferred Tax Assets	735.08	505.05	508.51	1,920	-	-
Other Long-Term Assets	141.26	287.6	901.23	1,110	136.16	297.29
Total Assets	139,565	140,090	135,058	132,202	122,937	128,446
Accounts Payable	7,065	5,348	8,692	13,130	10,451	16,824
Accrued Expenses	814.31	1,177	1,203	633.1	608.08	820.82
Short-Term Debt	-	7,940	11,447	10,000	10,000	5,000
Current Portion of Long-Term Debt	-	-	-	6,337	-	-
Current Portion of Leases	24.89	28.37	26.85	23.71	2.2	-
Current Income Taxes Payable	955.13	3,293	174.79	214.38	-	-
Current Unearned Revenue	-	-	-	178.69	570	570
Other Current Liabilities	3,041	1,160	1,241	1,222	1,072	3,718
Total Current Liabilities	11,901	18,946	22,785	31,738	22,703	26,933
Long-Term Debt	-	-	5,000	-	5,928	5,440
Long-Term Leases	15.13	33.61	25.78	63.55	47.89	41.17
Pension & Post-Retirement Benefits	102.62	-	-	-	147.96	662.77
Other Long-Term Liabilities	553.93	1,372	252.56	461.27	225.66	225.66
Total Liabilities	12,573	20,352	28,064	32,263	29,052	33,302
Common Stock	5,317	5,317	3,544	3,544	3,544	3,544
Additional Paid-In Capital	23,290	23,290	25,068	25,068	25,068	25,068
Retained Earnings	98,391	91,138	78,382	71,327	65,273	66,532
Treasury Stock	-5.35	-5.35	-	-	-	-
Comprehensive Income & Other	0	0	0	0	0	-
Shareholders' Equity	126,992	119,738	106,994	99,939	93,885	95,144
Total Liabilities & Equity	139,565	140,090	135,058	132,202	122,937	128,446
Total Debt	40.02	8,002	16,500	16,424	15,978	10,481
Net Cash (Debt)	12,815	-243.03	-11,135	-8,543	-3,340	-9,443
Net Cash Per Share	-	-22.86	-1570.78	-803.46	-314.15	-888.09
Filing Date Shares Outstanding	-	10.63	7.09	10.63	10.63	10.63
Total Common Shares Outstanding	-	10.63	7.09	10.63	10.63	10.63
Working Capital	54,210	45,288	33,786	20,302	17,786	13,544
Book Value Per Share	-	11261.43	15093.47	9398.78	8829.44	8947.82
Tangible Book Value	126,992	119,738	106,994	99,939	93,885	95,144
Tangible Book Value Per Share	-	11261.43	15093.47	9398.78	8829.44	8947.82
Land	8,047	7,933	7,933	7,880	7,832	7,669
Buildings	58,494	57,923	53,974	52,056	52,671	52,135
Machinery	45,382	48,332	47,960	43,826	43,765	43,531
Construction In Progress	400.5	96	2,326	554	408.55	476.55

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.